Laverdia-CA1 2.5 mg (50 tablets)

Laverdia-CA1 2.5mg for Dogs

Laverdia-CA1 (verdinexor) 2.5 mg is a prescription oral cancer treatment specifically formulated to treat canine lymphoma, a common and aggressive type of cancer in dogs. As the first FDA-approved oral treatment for lymphoma in dogs, Laverdia-CA1 offers a convenient, at-home alternative to injectable chemotherapy, helping to improve your dog’s quality of life with minimal clinic visits.

The active ingredient, verdinexor, is a Selective Inhibitor of Nuclear Export (SINE) compound that works by trapping tumor-suppressing proteins within the cell nucleus, triggering cancer cell death while sparing healthy cells.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

NOTE: For generic medications, the product image shown may not reflect the actual item received. Generic medications can vary in size, color, and shape between orders depending on the manufacturer. Additionally, your medication may arrive packaged in a HardyPaw Pharmacy vial.

Also Available In

Shop Laverdia-CA1 in multiple strengths to match your dog’s treatment needs:

• Laverdia-CA1 10 mg (Verdinexor) – Tablets for Dogs
  
• Laverdia-CA1 50 mg – Tablets for Dogs
  

What Are the Benefits of Using Laverdia-CA1 for Canine Lymphoma?

Laverdia-CA1 offers multiple benefits for dogs undergoing cancer treatment:

• Treats lymphoma with fewer clinical visits
• Targets cancer cells without harming healthy tissue
• Oral format improves ease of administration
• Reduces common chemotherapy side effects
• Helps extend quality of life for dogs with lymphoma

Is Laverdia-CA1 Right for My Dog?

If your dog has been diagnosed with lymphoma, Laverdia-CA1 may be a viable option for treatment at home. Dogs that are older, sensitive to chemotherapy, or require lower-stress care may benefit the most. Always consult your veterinarian before starting treatment.

How to Use Laverdia-CA1? (Dosage and Administration)

Always consult your veterinary for exact dosage instructions depending on your pet's condition.

Typical usage guidance includes:

• Tablets can be administered with or without food.
• Always wear gloves when handling this medication.
• Wash hands thoroughly after administration.

What to Expect After Starting Laverdia-CA1

Most pet parents report improvements in energy and comfort within 1–2 weeks of starting Laverdia-CA1. Monitor your dog closely for appetite, bathroom habits, and activity. Side effects, if any, are usually mild and manageable. Regular vet checkups are recommended during treatment.

What Are the Ingredients in Laverdia-CA1 2.5 mg?

Active Ingredient: 

• Verdinexor – 2.5 mg per tablet
  (A SINE compound designed to induce cancer cell death by blocking nuclear export of tumor suppressor proteins)

Inactive Ingredient:  Lactose monohydrate, povidone K30, croscarmellose sodium, magnesium stearate, microcrystalline cellulose

How Laverdia-CA1 Compares to Other Cancer Treatments

Are There Any Side Effects of Laverdia-CA1 for Dogs?

Some dogs may experience mild to moderate side effects such as:

• Vomiting or loss of appetite
• Lethargy
• Diarrhea
• Weight loss
• Low white blood cell counts in rare cases

📌 Important: If your dog shows signs of persistent vomiting, dehydration, or unusual behavior, contact your veterinarian immediately.

What Are the Warnings & Precautions for Laverdia-CA1?

• For use only in dogs diagnosed with lymphoma
• Not for use in breeding, pregnant, or lactating dogs
• Should not be used in dogs with severe liver or kidney issues
• Keep out of reach of children and other animals
• Use gloves when handling tablets
• Store in a cool, dry place away from sunlight

Shipping & Returns

Shipping Policy: HardyPaw offer all types of shipping options (Ground, Express, Priority, International) depending on the urgency of the product requirements. To know about our shipping policy in detail, click here.

Refund policy: If you face any issue with our product and want to return it, read our refund policy carefully.